HMGB1 and neoplasm: In addition, the induction of tumor ICD via radiotherapy or chemotherapy can also activate the T-cell immune response by releasing large amounts of tumor antigens and signaling molecules (Zhu et al., 2021), including calreticulin (CRT) exposed on the cell surface, high mobility group protein 1 (HMGB1), and ATP molecules.